DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
RG1662 is an investigational drug.
There have been 9 clinical trials for RG1662. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2014.
The most common disease conditions in clinical trials are Down Syndrome, Syndrome, and [disabled in preview]. The leading clinical trial sponsors are Hoffmann-La Roche and [disabled in preview].
There are thirteen US patents protecting this investigational drug and one hundred and fifty-three international patents.
Recent Clinical Trials for RG1662
|A Study of RG1662 in Down Syndrome Among Children 6 to 11 Years of Age||Hoffmann-La Roche||Phase 2|
|A Brain Imaging Study to Assess GABAA Receptor Alpha5 Subunit Occupancy Following a Single Dose of RO5186582 in Japanese Healthy Volunteers.||Hoffmann-La Roche||Phase 1|
|A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RG1662 in Healthy Subjects||Hoffmann-La Roche||Phase 1|
Top disease conditions for RG1662
Top clinical trial sponsors for RG1662
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|RG1662||Get Started for $10||Controlled release dosage form||TRIASTEK, INC. (Nanjing, CN)||Get Started for $10|
|RG1662||Get Started for $10||Oral drug dosage forms having desired drug release profiles and uses thereof||Triastek, Inc. (Nanjing, CN)||Get Started for $10|
|RG1662||Get Started for $10||Compartmented pharmaceutical dosage forms||Triastek, Inc. (Nanjing, CN)||Get Started for $10|
|RG1662||Get Started for $10||Compositions and methods for neurological diseases||Coda Biotherapeutics, Inc. (South San Francisco, CA)||Get Started for $10|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|RG1662||Australia||AU2017261372||2036-05-05||Get Started for $10|
|RG1662||Canada||CA3023278||2036-05-05||Get Started for $10|
|RG1662||China||CN107847398||2036-05-05||Get Started for $10|
|RG1662||European Patent Office||EP3452003||2036-05-05||Get Started for $10|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|